Scholar Rock (NASDAQ: SRRK) net income
Scholar Rock reported a net loss of $377.9m for fiscal 2025; in fiscal 2024 it reported a net loss of $246.3m. Earnings per share were −$3.29.
Scholar Rock's best year of the last 9 was fiscal 2017. It reported a loss in 9 of those 9 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$377.9m | — | — | −$3.29 |
| 2024 | −$246.3m | — | — | −$2.47 |
| 2023 | −$165.8m | — | — | −$1.99 |
| 2022 | −$134.5m | — | −405.2% | −$2.26 |
| 2021 | −$131.8m | — | −700.5% | −$3.59 |
| 2020 | −$86.5m | — | −561.5% | −$2.81 |
| 2019 | −$51.0m | — | −248.9% | — |
| 2018 | −$49.3m | — | — | — |
| 2017 | −$25.0m | — | — | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Scholar Rock net income compared with its sector
By net income for its latest fiscal year, Scholar Rock ranks 462nd of the 501 US health care companies with a page on Celsmar.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 460th | Myriad Genetics | −$365.9m | −44.4% |
| 461st | Zenas BioPharma | −$377.7m | −3,777.4% |
| 462nd | Scholar Rock | −$377.9m | — |
| 463rd | Ionis Pharmaceuticals | −$381.4m | −40.4% |
| 464th | Iovance Biotherapeutics | −$391.0m | −148.4% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Scholar Rock
- How much did Scholar Rock earn in fiscal 2025?
- Scholar Rock reported a net loss of $377.9m for fiscal 2025. In fiscal 2024 it reported a net loss of $246.3m.
- What are the earnings per share of Scholar Rock?
- They were −$3.29 in fiscal 2025, compared with −$2.47 in fiscal 2024.
- Where does Scholar Rock rank in its sector by net income?
- It ranks 462nd of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Scholar Rock come from?
- From the annual report (Form 10-K) that Scholar Rock files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Scholar Rock files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on Scholar Rock: the Scholar Rock page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.